Boulder, CO, United States of America

Robert E Blomquist

This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Transformative Biotech, LLC, University of Colorado. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert E Blomquist. Retrieved from https://idiyas.com/inventor/robert-e-blomquist-w7c4og4v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert E. Blomquist

Introduction

Robert E. Blomquist is a notable inventor based in Boulder, Colorado. He has made significant contributions to the field of infectious disease diagnostics. His work focuses on developing methods that enhance the accuracy and efficiency of pathogen testing.

Latest Patents

Robert E. Blomquist holds a patent for "Extraction-free pathogen testing methods." This invention provides compositions and methods that allow for rapid, accurate, robust, and low-cost diagnosis of infectious diseases through extraction-free, direct PCR techniques. His innovative approach has the potential to transform how infectious diseases are diagnosed.

Career Highlights

Throughout his career, Blomquist has worked with various organizations, including Transformative Biotech, LLC and the University of Colorado. His experience in these institutions has contributed to his expertise in biotechnology and diagnostics.

Collaborations

Some of his notable coworkers include Shi-Long Lu and Brian L. Harry. Their collaborative efforts have further advanced the research and development of diagnostic methods in the field.

Conclusion

Robert E. Blomquist's contributions to pathogen testing represent a significant advancement in medical diagnostics. His innovative methods are paving the way for more efficient and cost-effective solutions in the fight against infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…